Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Population and brain diversity are missing from the integrated framework of MS susceptibility.
Response to "comment on 'evidence for compromised function of the glymphatic system in pediatric acquired demyelinating disorders'".
Effectiveness of Blood Flow Restriction Training in Neurological Rehabilitation: A Systematic Review and Meta-analysis.
Bilateral Optic Neuritis in Paediatric Acute Disseminated Encephalomyelitis: A Case Report of Clinical Challenges and Management Outcomes.
Differential safety profiles of disease-modifying therapies in MS: Age- and sex-based analysis from a real-world cohort.
Ofatumumab and enteroviral encephalitis: a severe infectious complication as a class effect with anti-CD20 therapies.
Oral antipyretics for fatigue alleviation and exercise enhancement in adults with multiple sclerosis: a systematic review and meta-analysis.
Radiomics Applied to the Diagnosis of Peripheral Nerve Disorders: A Systematic Review and Meta-Analysis of the Existing Literature.
Drug-induced sarcoidosis-like reaction following IL-4/IL-13 receptor blockade by dupilumab.
Validation of a new diagnostic ELISA to detect anti-JCV antibodies in serum of patients with multiple sclerosis considering or receiving treatment with natalizumab.
When is the Radiologically Isolated Syndrome already Multiple Sclerosis According to the 2024 McDonald Criteria?
Natalizumab for pediatric multiple sclerosis: a systematic review and meta-analysis.
Neuroectodermal interleukin 12 signaling attenuates spinal cord inflammation and demyelination.
NEK7 Cys298 is important for NLRP3 inflammasome and targetable by dimethyl fumarate.
Associations of plasma phosphorylated tau217 with cognitive impairment and brain microstructural alterations in Alzheimer's disease.
Aloe-emodin promotes remyelination by driving microglial myelin debris clearance via the CD36-PPARγ axis.
Diagnostic Performance of Quantitative T1rho MRI for the Assessment of Disease Activity in Relapsing-Remitting Multiple Sclerosis.
Data-driven hypothesis discovery from disease trajectories in multiple sclerosis.
Pilates as therapy for multiple sclerosis: current perspective and future directions.
A Functional Shape Framework for the Detection of Multiple Sclerosis Using Optical Coherence Tomography Images.
#MultipleSclerosis: Artificial intelligence-based sentiment and content analysis of Tweets.
Interleukin-40 and Soluble CD40 Ligand in Multiple Sclerosis: Inflammatory Signals or Clinically Applicable Biomarkers?
Cortical Lesions Form Predominantly in Early Multiple Sclerosis.
Longitudinal changes in serum protein levels are associated with disability progression in multiple sclerosis.
1,3,4 oxadiazole derivative attenuates neurotransmitter-mediated inflammatory response in EAE model of multiple sclerosis.
Pages
« first
‹ previous
…
989
990
991
992
993
994
995
996
997
…
next ›
last »